Torcozia

Torcozia Dosage/Direction for Use

etoricoxib

Manufacturer:

Community Pharm PCL

Distributor:

Community Pharm PCL

Marketer:

Community Pharm PCL
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Dosage/Direction for Use
Rheumatoid arthritis: The recommended dose is 90 mg once daily.
Ankylosing spondylitis: The recommended dose is 90 mg once daily.
Acute pain: For acute pain conditions, TORCOZIA 90 MG should be used only for the acute symptomatic period.
Post-operative dental pain: The recommended dose is 90 mg once daily for up to 3 days.
Post-operative gynecological pain: The recommended dose is 90 mg once daily for up to 5 days. The initial dose should be administered shortly before surgery. The dose can be increased to a maximum 120 mg once daily.
Hepatic insufficiency: Etoricoxib 90 mg tablet is not for use in patients with mild or moderate hepatic insufficiency.
In patients with mild hepatic insufficiency (Child-Pugh score 5-6), a dose of 60 mg once daily should not be exceeded.
In patients with moderate hepatic insufficiency (Child-Pugh score 7-9), the dose should be reduced; a dose of 60 mg every other day should not be exceeded, administration of 30 mg once daily can also be considered.
There are no clinical or pharmacokinetic data in patients with severe hepatic insufficiency (Child-Pugh score >9).
Use is contraindicated in severe hepatic insufficiency.
Renal Insufficiency: Creatinine clearance <30 mL/min: Use is contraindicated.
Creatinine clearance ≥30 mL/min: No dosage adjustment necessary.
Mode of Administration: TORCOZIA 90 MG is administered orally. TORCOZIA 90 MG may be administered without regard to meal.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in